AVR Stock Overview

Profile

Full Name:

Anteris Technologies Global Corp.

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

Country:

Australia

IPO:

January 24, 2020

Indexes:

Not included

Website:

http://anteristech.com

Description:

Anteris Technologies is a medical technology company focused on developing innovative solutions for heart valve replacement and repair, aiming to improve patient outcomes in cardiovascular health.

Key Details

Price

$8.25

Market Cap

$296.50 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$2.73 M(-14.56% YoY)

Annual EPS

-$1.28(-50.58% YoY)

PE Ratio

-

Annual ROE

-329.54%

Annual Debt To Equity

0.00

Beta

-0.46

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 8, 25 Lake Street
Buy
Jan 7, 25 TD Cowen
Buy
Jan 7, 25 Cantor Fitzgerald
Overweight
Jan 7, 25 Barclays
Overweight

Screeners with AVR included

Most recommended stocks
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
Stocks with high RSI
Small cap stocks
Stocks with low beta
Recommended stocks with new highs
Medical Instruments & Supplies industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$8.25
AVR price is $8.25

Price All-time High

$8.54
AVR price is currently -3.40% below its historical high of $8.54

Price Analysts Target

$17.50
AVR price is currently -52.86% lower than the consensus analysts' forecast

Price Most Recent Change

-0.24%
AVR price was down -0.24% on Feb 21, 2025

Price YTD Change

+47.85%
AVR price is up +47.85% since January 1st

Price 3-Year Change

-
AVR price 3-year change is unknown

Market cap

Market Cap

$296.50 M
AVR market capitalization is $296.50 million

Market Cap 3-Year Change

-
AVR market capitalization 3-year change is unknown

Market Cap All-time High

$306.93 M
AVR market capitalization is currently -3.40% below its historical high of $306.93 million

Market Cap Sector Rank

60.33%
AVR market capitalization is higher than 60.33% of companies in Healthcare sector

Technical

Beta

-0.46
AVR beta is -0.46

200-day SMA

$6.24
AVR price is currently +32.31% above its 200-day simple moving average

14-day RSI

73.05
AVR 14-day relative strength index is 73.05

30-day Relative Volume

0.94
AVR 30-day relative volume is 0.94

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$2.73 M
AVR annual revenue is $2.73 million

Annual Revenue Analysts Estimate

$4.91 M
AVR annual revenue is currently -44.32% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-14.56%
AVR annual revenue is down -14.56% year-on-year

Annual Revenue Sector Rank

18.64%
AVR annual revenue is higher than 18.64% of companies in Healthcare sector

Profit

Annual Gross Profit

$876.80 K
AVR annual gross profit is $876.80 thousand

Annual Gross Margin

32.06%
AVR annual gross profit margin is 32.06%

Annual Operating Profit

-$46.79 M
AVR annual operating income is -$46.79 million

Annual Operating Margin

-1710.83%
AVR annual operating profit margin is -1710.83%

Annual Net Income

-$46.02 M
AVR annual net profit is -$46.02 million

Annual Net Margin

-1682.81%
AVR annual net profit margin is -1682.81%

EPS

Annual EPS

-$1.28
AVR annual earnings per share is -$1.28

Annual EPS Analysts Estimate

-$2.92
AVR annual earnings per share is currently -56.15% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-50.58%
AVR annual earnings per share is down -50.58% year-on-year

Annual EPS Sector Rank

54.94%
AVR annual earnings per share is higher than 54.94% of companies in Healthcare sector

ROA & ROE

Annual ROA

-197.89%
AVR annual return on assets is -197.89%

Annual ROE

-329.54%
AVR annual return on equity is -329.54%

EBIT & EBITDA

Annual EBIT

-$46.70 M
AVR annual earnings before interest & taxes is -$46.70 million

Annual EBITDA

-$45.54 M
AVR annual EBITDA is -$45.54 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
AVR price to earnings ratio value is unknown

PE Ratio Sector Rank

-
AVR price to earnings ratio is unknown

PB Ratio

PB Ratio

94.14
AVR price to book ratio is 94.14

PB Ratio Sector Rank

98.69%
AVR price to book ratio is higher than 98.69% of companies in Healthcare sector

PS Ratio

PS Ratio

109.37
AVR price to sales ratio is 109.37

PS Ratio Sector Rank

94.99%
AVR price to sales ratio is higher than 94.99% of companies in Healthcare sector

Enterprise value

Enterprise Value

$289.08 M
AVR enterprise value is $289.08 million

Enterprise Value Sector Rank

61.75%
AVR enterprise value is higher than 61.75% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.12
AVR EV/EBITDA is -4.12

EV/EBITDA Sector Rank

27.24%
AVR EV/EBITDA is higher than 27.24% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.56
AVR annual current ratio is 2.56

Annual Quick Ratio

2.51
AVR annual quick ratio is 2.51

Leverage

Annual Debt To Equity

0.00
AVR annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-695.92
AVR annual interest coverage ratio is -695.92

Risk & Stability

Piotroski F-Score

-
AVR piotroski f-score value is unknown

Altman Z-Score

1.74
AVR altman z-score is 1.74

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$30.53 M
AVR annual total assets is $30.53 million

Annual Non Current Assets

$6.31 M
AVR annual long term assets is $6.31 million

Annual Current Assets

$24.22 M
AVR annual total current assets is $24.22 million

Annual Cash & Cash Equivalents

$21.03 M
AVR annual cash & cash equivalents is $21.03 million

Equity

Annual Book Value

$19.30 M
AVR annual book value is $19.30 million

Annual Working Capital

$14.77 M
AVR annual working capital is $14.77 million

Liabilities

Annual Total Liabilities

$11.63 M
AVR annual total liabilities is $11.63 million

Annual Total Long Term Liabilities

$2.17 M
AVR annual total long term liabilities is $2.17 million

Annual Current Liabilities

$9.46 M
AVR annual total current liabilities is $9.46 million

Annual Accounts Payable

$3.14 M
AVR annual accounts payable is $3.14 million

Debt

Annual Total Debt

$1.60 M
AVR annual total debt is $1.60 million

Annual Total Debt 1-Year Change

+67.47%
AVR annual total debt is up +67.47% year-on-year

Annual Long Term Debt

$926.80 K
AVR annual long term debt is $926.80 thousand

Annual Short Term Debt

$668.90 K
AVR annual short term debt is $668.90 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$49.52 M
AVR annual total expenses is $49.52 million

Annual Operating Expenses

$47.66 M
AVR annual total operating expenses is $47.66 million

Annual Cost Of Goods Sold

$1.86 M
AVR annual cost of goods sold is $1.86 million

Annual SGA

$17.05 M
AVR annual SGA is $17.05 million

Annual D&A

$1.16 M
AVR annual depreciation & amortization is $1.16 million

Annual Interest Expense

$67.10 K
AVR annual interest expense is $67.10 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$34.63 M
AVR annual cash flow from operations is -$34.63 million

Annual CFO 1-Year Change

-17.73%
AVR annual cash flow from operations is down -17.73% year-on-year

Annual CFI

-$2.58 M
AVR annual cash flow from investing activities is -$2.58 million

Annual CFI 1-Year Change

-160.09%
AVR annual cash flow from investing activities is down -160.09% year-on-year

Annual CFF

$49.34 M
AVR annual cash flow from financing activities is $49.34 million

Annual CFF 1-Year Change

+112.02%
AVR annual cash flow from financing activities is up +112.02% year-on-year

Free CashFlow

Annual FCF

-$37.03 M
AVR annual free cash flow is -$37.03 million

Annual FCF 1-Year Change

-19.12%
AVR annual free cash flow is down -19.12% year-on-year

CAPEX

Annual CAPEX

$2.39 M
AVR annual capital expenditures is $2.39 million

Annual CAPEX 1-Year Change

+43.75%
AVR annual capital expenditures is up +43.75% year-on-year

Institutional Ownership

Similar stocks

OLMA logo
Olema Pharmaceuticals (OLMA)
SMTI logo
Sanara MedTech (SMTI)
Aardvark Therapeutics (AARD)
CERS logo
Cerus (CERS)
IRWD logo
Ironwood Pharmaceuticals (IRWD)
IMMP logo
Immutep Limited (IMMP)
CMPS logo
COMPASS Pathways (CMPS)
VMD logo
Viemed Healthcare (VMD)
RZLT logo
Rezolute (RZLT)

FAQ

  • What is the ticker symbol for Anteris Technologies Global Corp?
  • Does Anteris Technologies Global Corp pay dividends?
  • What sector is Anteris Technologies Global Corp in?
  • What industry is Anteris Technologies Global Corp in?
  • What country is Anteris Technologies Global Corp based in?
  • When did Anteris Technologies Global Corp go public?
  • Is Anteris Technologies Global Corp in the S&P 500?
  • Is Anteris Technologies Global Corp in the NASDAQ 100?
  • Is Anteris Technologies Global Corp in the Dow Jones?
  • When does Anteris Technologies Global Corp report earnings?
  • Should I buy Anteris Technologies Global Corp stock now?

What is the ticker symbol for Anteris Technologies Global Corp?

The ticker symbol for Anteris Technologies Global Corp is NASDAQ:AVR

Does Anteris Technologies Global Corp pay dividends?

No, Anteris Technologies Global Corp does not pay dividends

What sector is Anteris Technologies Global Corp in?

Anteris Technologies Global Corp is in the Healthcare sector

What industry is Anteris Technologies Global Corp in?

Anteris Technologies Global Corp is in the Medical Instruments & Supplies industry

What country is Anteris Technologies Global Corp based in?

Anteris Technologies Global Corp is headquartered in Australia

When did Anteris Technologies Global Corp go public?

Anteris Technologies Global Corp's initial public offering (IPO) was on January 24, 2020

Is Anteris Technologies Global Corp in the S&P 500?

No, Anteris Technologies Global Corp is not included in the S&P 500 index

Is Anteris Technologies Global Corp in the NASDAQ 100?

No, Anteris Technologies Global Corp is not included in the NASDAQ 100 index

Is Anteris Technologies Global Corp in the Dow Jones?

No, Anteris Technologies Global Corp is not included in the Dow Jones index

When does Anteris Technologies Global Corp report earnings?

The date for Anteris Technologies Global Corp's next earnings report has not been announced yet

Should I buy Anteris Technologies Global Corp stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions